Home › Funds › ARCH Venture Management, LLC › SPTX
ARCH Venture Management, LLC position in SPTX
SEAPORT THERAPEUTICS INC · Health Care
ARCH Venture Management, LLC reported holding 6,294,951 shares of SPTX (SEAPORT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$127.0M, representing 7.87% of its reported portfolio and ranking #5 among its reported holdings. ARCH Venture Management, LLC has disclosed SPTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How ARCH Venture Management, LLC's SPTX position evolved
ARCH Venture Management, LLC first disclosed a stake in SPTX in Q2 2026 at 6,294,951 shares (US$136.6M). Across 2 filings, ARCH Venture Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 6,294,951 shares valued at US$127.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 6.29M | $136.60M | New |
| Q3 2026 | 6.29M | $126.97M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SPTX and 13F data
SPTX (SEAPORT THERAPEUTICS INC) is a Health Care company. 77 other funds we track also report a position in SPTX — the largest reported positions include GENERAL ATLANTIC, L.P. (US$123.1M), Sofinnova Investments, Inc. (US$71.9M), TRV GP VI, LLC (US$41.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SPTX
- GENERAL ATLANTIC, L.P. 6.10M sh · $123.07M · Q3 2026
- Sofinnova Investments, Inc. 3.56M sh · $71.90M · Q3 2026
- TRV GP VI, LLC 2.06M sh · $41.57M · Q3 2026
- Foresite Capital Management VI LLC 1.78M sh · $35.89M · Q3 2026
- Bellevue Group AG 1.10M sh · $22.19M · Q3 2026
- Siren, L.L.C. 1.10M sh · $22.09M · Q3 2026
More on ARCH Venture Management, LLC
FAQ
How long has ARCH Venture Management, LLC held SPTX?
ARCH Venture Management, LLC has disclosed SPTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ARCH Venture Management, LLC's current position in SPTX?
As of Q3 2026, ARCH Venture Management, LLC holds 6.29M shares of SPTX (SEAPORT THERAPEUTICS INC), valued at $126.97M, representing 7.87% of its reported portfolio and ranking #5.
Has ARCH Venture Management, LLC been buying or selling SPTX?
In the latest 13F filing (Q3 2026), ARCH Venture Management, LLC held unchanged its position in SPTX.
Which other funds hold SPTX?
Other major institutional holders of SPTX include GENERAL ATLANTIC, L.P., Sofinnova Investments, Inc., TRV GP VI, LLC, among 77 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.